Stocks under Profitability Radar: Corindus Vascular Robotics, Inc. (NYSE:CVRS)

Corindus Vascular Robotics, Inc. (NYSE:CVRS) persists its position slightly strong in context of buying side, while shares price build up 19.49% during latest trading session. Finally to see some strong financial remarks by WSJ over CVRS performance. Out of the pool of analysts 3 gave their BUY ratings on the stock in previous month as 3 analysts having BUY in current month. The stock was ranked as Underweight by 1 analyst while 1 analyst gave SELL rank. Majority ranked Buy from the pool of analysts.

The next year first quarter EPS estimates trend for current period shows $-0.07 while one month ago this estimate trend was for $-0.07. EPS indicator shows the robustness of the stock and its analysis opens up the clear picture of company’s profitability. On annual basis of EPS, FY 2017 Estimate Trends at current were for $-0.31 and for the one month was for $-0.25 as compared to three months ago was for $-0.25. CVRS received highest price target of 3 and low target of 2.50. The stock price target chart showed average price target of 2.83 as compared to current price of 1.41.

Narrow down focus to other ratios, the Corindus Vascular Robotics, Inc. (NYSE:CVRS) has current ratio of 2.50 that indicates if ratio lies in 1.3% to 3% then it is acceptable for both active and passive investors, but sometimes its varies industry to industry. Generally, it indicates good short-term financial strength. To make strengthen these views, the active industry firm has Quick Ratio of 2.30, which indicates firm has sufficient short-term assets to cover its immediate liabilities. In addition, the firm has debt to equity ratio of 0.37, sometimes it remain same with long term debt to equity ratio.

Analysts Pools

Finally to see some strong financial remarks by WSJ over CVRS performance. Out of the pool of analysts 3 gave their BUY ratings on the stock in previous month as 3 analysts having BUY in current month. The stock was ranked as Underweight by 1 analyst while 1 analyst gave SELL rank. Majority ranked Buy from the pool of analysts.

The next year first quarter EPS estimates trend for current period shows $-0.07 while one month ago this estimate trend was for $-0.07. EPS indicator shows the robustness of the stock and its analysis opens up the clear picture of company’s profitability. On annual basis of EPS, FY 2017 Estimate Trends at current were for $-0.31 and for the one month was for $-0.25 as compared to three months ago was for $-0.25. CVRS received highest price target of 3 and low target of 2.50. The stock price target chart showed average price target of 2.83 as compared to current price of 1.41.

Profitability Analysis

To stick with focus on profitability valuation, Corindus Vascular Robotics, Inc. (NYSE:CVRS) also listed in significant eye catching mover, CVRS attains returns on investment ratio of -62.50%, which suggests it’s viable on security that has lesser ROI.

The gross profit margin can be giving more focus view that is -49.00%. Turns back to returns ratios, the co’s returns on assets calculated as -62.50%; that gives an idea as to how efficient management is at using its assets to generate earnings. Finally yet importantly, returns on equity stand at -125.00%.

EPS estimates indicating constrictive facts, the current year from sell-side analysts, Price to current year EPS of Corindus Vascular Robotics, Inc. (NYSE:CVRS) stands at 12.00%, and looking further price to next year’s EPS is -14.80%. While take a short look on price to sales ratio, that was 52.64.

 

About Blake Escott

Blake Escott holds junior writer position in SWR. Before joining Streetwise Report, he was a freelance content Writer. He has high-level copywriting experience and particularly experienced in proofreading and editing. He covers news about different companies including all US market sectors. Interests: Commodities, Energy stocks, Sector-wise Stocks analysis, Utilities

Leave a Reply

Your email address will not be published. Required fields are marked *